Jump to content

Leptosidin

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 03:34, 15 April 2020 (Open access bot: doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Leptosidin
Names
IUPAC name
(2Z)-2-[(3,4-Dihydroxyphenyl)methylidene]-6-hydroxy-7-methoxy-1-benzofuran-3-one
Identifiers
3D model (JSmol)
ChemSpider
KEGG
  • InChI=1S/C16H12O6/c1-21-16-11(18)5-3-9-14(20)13(22-15(9)16)7-8-2-4-10(17)12(19)6-8/h2-7,17-19H,1H3/b13-7- ☒N
    Key: PFRGTMTYWMVLMU-QPEQYQDCSA-N ☒N
  • InChI=1/C16H12O6/c1-21-16-11(18)5-3-9-14(20)13(22-15(9)16)7-8-2-4-10(17)12(19)6-8/h2-7,17-19H,1H3/b13-7-
    Key: PFRGTMTYWMVLMU-QPEQYQDCBV
  • COc(c(O)3)c(o1)c(cc3)c(=O)c(=Cc(c2)cc(O)c(O)c2)1
Properties
C16H12O6
Molar mass 300.266 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Leptosidin was the first aurone to be isolated in Coreopsis grandiflora by Geissman T.A. and Heaton C.D. in 1943.[1] Leptosidin blocks the active residues of PRKACA.[2]

References

  1. ^ Leptosidin on metabolomics.jp
  2. ^ s, Sandeep; v, Priyadarshini; d, Pradhan; m, Munikumar; a, Umamaheswari (2012). "Docking and molecular dynamics simulations studies of human protein kinase catalytic subunit alpha with antagonist". Journal of Clinical and Scientific Research: 15–23. doi:10.15380/2277-5706.JCSR.12.005.